Keyword: Alzheimer’s disease
News
24.11.2016
- Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...
Plant Construction & Process Technology
08.09.2016
- Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...
News
03.06.2016
- Biogen’s investigational treatment for early Alzheimer’s disease (AD), aducanumab, has been accepted into the European Medicines Agency’s (EMA) PRIority MEdicines (PRIME) program...
News
27.10.2015
- Biogen has announced a corporate restructuring scheme that will lead it to terminate a number of drug pipeline programs while cutting the workforce by 11% up to the end of this...
News
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
News
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
News
16.07.2014
- Novartis is collaborating with Phoenix, Arizona-based US non-profit Banner Alzheimer's Institute (BAI) on a clinical study to determine whether two of the Swiss pharmaceutical...
